Press Room
April 24, 2006
Cognis reagent achieves kosher certification
Specialty chemicals supplier Cognis has increased the number of kosher products in its range: Aliquat® 134 Reagent (also known as Aliquat® 336) , the company’s highly concentrated, high-purity quaternary ammonium salt, was recently certified kosher by the Organized Kashrus Laboratories. Offering kosher products is part of Cognis’ efforts to help its customers meet the needs of consumers from diverse ethnic and religious groups.
Kosher certification is an essential purchasing criterion for millions of consumers of food and medical products around the world, particularly for adherents of the Jewish faith. By achieving this certification for Aliquat 134 Reagent, a quaternary ammonium salt used as a phase transfer catalyst and solvent extraction agent, Cognis is expanding its range of products for kosher consumers of personal care, food and pharmaceutical products.
Kosher certification is also seen as a sign of quality by many consumers who are not religiously motivated. Certified products which do not contain meat or dairy are also popular with vegetarians and people with lactose allergies respectively. They can also be uses as substitutes to meet Islamic dietary restrictions. Comments Chris Koob, Global Business Manger Ion-Transfer Technology: “By expanding our comprehensive portfolio of kosher products, we are enabling our customers around the world to fulfill growing specific consumer expectations.”
About Cognis
Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. The company employs about 8,000 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The company holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of natural-source oleochemical basestocks. working
Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2005, Cognis recorded sales of 3.18 billion euros and an Adjusted EBITDA (earnings before interest, income taxes, depreciation, amortization and exceptional items) of 356 million euros.
Contact
Raquel Ark, Corporate Communications Manager
Cognis Deutschland GmbH & Co. KG
Phone: +49-2173-4995 464
E-mail: raquel.ark@cognis.com
Internet: www.cognis.com
Chris Koob, Global Business Manager
Ion-Transfer Technology
Cognis Corporation
Phone: +1-520-629-3204
E-mail: chris.koob@cognis.com
Internet: www.cognis.com